Management of persistent gastric bleeding in a patient with Glanzmann's thrombasthenia

American Journal of Hematology

Volumn 83, Issue 5, 2008, Pages 411-415

  Bakdash, Suzanne ^a,b   Lyons, John M ^a   Bastacky, Sheldon I ^a   Pezzone, Michael A ^a   McGee, James B ^a   Schoen, Robert E ^a   Regueiro, Miguel ^a   Lee, Kenneth K ^a   Bontempo, Franklin A ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; PROTON PUMP INHIBITOR; RANITIDINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ALLOIMMUNIZATION; ARGON PLASMA COAGULATION; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COLONOSCOPY; ERYTHROCYTE TRANSFUSION; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GLANZMANN DISEASE; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HISTOPATHOLOGY; HLA MATCHING; HUMAN; IRON DEFICIENCY ANEMIA; MENORRHAGIA; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; STOMACH HEMORRHAGE; STOMACH POLYP; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; UPPER GASTROINTESTINAL BLEEDING;

ANEMIA, IRON-DEFICIENCY; CASE MANAGEMENT; COMBINED MODALITY THERAPY; ERYTHROCYTE TRANSFUSION; FACTOR VIIA; FEMALE; GASTRECTOMY; GASTRIC FUNDUS; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HUMANS; IRON; LAPAROSCOPY; MIDDLE AGED; PLATELET TRANSFUSION; POLYPS; RECOMBINANT PROTEINS; STOMACH DISEASES; SURGICAL INSTRUMENTS; THROMBASTHENIA;

EID: 42949160969     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21122     Document Type: Article

References (21)

1. Bolton-Maggs PH, Chalmers EA, Collins PW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006;135:603-633.
2. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006;1:10.
3. Nair S, Ghosh K, Kulkarni B, et al. Glanzmann's thrombasthenia: Updated. Platelets 2002;13:387-393.
4. van Buuren HR, Wielenga JJ. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia. Dig Dis Sci 2002;47:2134-2136.
5. Gottschall J, Triulzi DJ, et al., editors. Blood Transfusion Therapy: A Physician's Handbook, 8th ed. Bethesda, MD: AABB; 2005.
6. Poon MC, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999;94:3951-3953.
7. Poon MC, D'Oiron R, Hann I, et al. Use of recombinant factor VIIa (NovoS-even) in patients with Glanzmann thrombasthenia. Semin Hematol 2001;38(4, Suppl 12):21-25.
8. Poon MC, D'Oiron R, Von Depka M, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey. J Thromb Haemost 2004;2:1096-1103.
9. Bell JA, Savidge GF. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost 2003;9:167-170.
10. Ismael F, van der Meer J, de Wolf JT, et al. Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia. Anesth Analg 2006;103:791-792.
11. Dargaud Y, Bordet JC, Trzeciak MC, et al. A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: Observations on the monitoring and the mechanism of action of this drug. Haematologica 2006;91(6, Suppl):ECR20.
12. Poon MC, Zotz R, Di Minno G, et al. Glanzmann's thrombasthenia treatment: A prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. Semin Hematol 2006;43(1, Suppl 1):S33-S36.
13. Poon MC. The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders. Transfus Med Rev 2007;21:223-236.
14. Monte S, Lyons G. Peripartum management of a patient with Glanzmann's thrombasthenia using thrombelastograph. Br J Anaesth 2002;88:734-738.
15. Marchant W, Mallet S. Platelet function assessment in Glanzmann's thrombasthenia. Br J Anaesth 2002;89:525.
16. Male C, Koren D, Eichelberger B, et al. Monitoring survival and function of transfused platelets in Glanzmann thrombasthenia by flow cytometry and thrombelastography. Vox Sang 2006;91:174-177.
17. Harrison P. Platelet function analysis. Blood Rev 2005;19:111-123.
18. Cardigan R, Turner C, Harrison P. Current methods of assessing platelet function: Relevance to transfusion medicine. Vox Sang 2005;88:153-163.
19. Burt RW. Gastric fundic gland polyps. Gastroenterology 2003;125:1462-1469.
20. Jalving M, Koornstra JJ, Wesseling J, et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006;24:1341-1348.
21. Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol 2001;116:716-720.